Skip to main content
. 2020 Apr 15;11:295. doi: 10.3389/fpsyt.2020.00295

Figure 7.

Figure 7

Results of the effect of paeonol on the premenstrual dysphoric disorder-progesterone withdrawal (PMDD-PWD) rat model in the elevated plus maze (EPM) test. (A) Total distance in the EPM test. (B) Distance in the closed arm in the EPM test. (C) Closed arm entry times in the EPM test. (D) Total entry times in the EPM test. (E) Percentage of time in the open arm in the EPM test. (F) Percentage of open-arm entry times in the EPM test. PMDD-PWD, premenstrual dysphoric disorder-progesterone withdrawal; EPM, elevated plus maze; Flx, fluoxetine; Pae, paeonol; *p < 0.05 compared with the control group; **p < 0.01 compared with the control group; #p < 0.05 compared with the PMDD-PWD group; ##p < 0.01 compared with the PMDD-PWD group. Twelve animals were used in each group.